Baxter commences CD34+ stem cell stage III trial in CMI Baxter International Inc. announced today that it offers initiated a stage III pivotal scientific trial to judge the efficacy and protection of adult autologous CD34+ stem cells to improve exercise capacity in sufferers with chronic myocardial ischemia . Chronic myocardial ischemia is among the most severe types of coronary artery disease, leading to significant long-term harm to the heart muscle mass and disability to the individual. It is diagnosed predicated on symptoms of severe, refractory angina, which is normally serious chest discomfort that will not react to conventional medical administration or surgical interventions.In 2000, McDonald’s, Burger King, Pringles and McCain opposed Monsanto’s genetically engineered New Leaf potatoes. Their opposition kept these Bt-spliced Frankenspuds off the market. Similarly, opposition to Monsanto’s GE wheat in 2003, not merely by U.S. Wheat farmers, but also by General Mills and Frito-Lay, killed the commercialization of this multi-billion dollar crop. And it had been consumer pressure that pressured Starbucks and other espresso brands to keep GE coffee off the market.